<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/393231</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;393231</article-id><article-id pub-id-type="other" hwp:sub-type="slug">393231</article-id><article-id pub-id-type="other" hwp:sub-type="tag">393231</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Contradictory Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Genetics" hwp:journal="biorxiv"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Re-Evaluating One-step Generation of Mice Carrying Conditional Alleles by CRISPR-Cas9-Mediated Genome Editing Technology</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2"><label>*</label>Corresponding authors: <email hwp:id="email-1">cgurumurthy@unmc.edu</email> and <email hwp:id="email-2">gaetan.burgio@anu.edu.au</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8022-4033</contrib-id><name name-style="western" hwp:sortable="Gurumurthy Channabasavaiah"><surname>Gurumurthy</surname><given-names>Channabasavaiah</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-8022-4033"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Quadros Rolen"><surname>Quadros</surname><given-names>Rolen</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Adams John Jr"><surname>Adams</surname><given-names>John</given-names><suffix>Jr</suffix></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Alcaide Pilar"><surname>Alcaide</surname><given-names>Pilar</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Ayabe Shinya"><surname>Ayabe</surname><given-names>Shinya</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Ballard Johnathan"><surname>Ballard</surname><given-names>Johnathan</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Batra Surinder K."><surname>Batra</surname><given-names>Surinder K.</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Beauchamp Marie-Claude"><surname>Beauchamp</surname><given-names>Marie-Claude</given-names></name><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Becker Kathleen A"><surname>Becker</surname><given-names>Kathleen A</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Bernas Guillaume"><surname>Bernas</surname><given-names>Guillaume</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-1" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Brough David"><surname>Brough</surname><given-names>David</given-names></name><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-1" hwp:rel-id="aff-10">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Carrillo-Salinas Francisco"><surname>Carrillo-Salinas</surname><given-names>Francisco</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Dawson Ruby"><surname>Dawson</surname><given-names>Ruby</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-1" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="DeMambro Victoria"><surname>DeMambro</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-2" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><name name-style="western" hwp:sortable="D’Hont Jinke"><surname>D’Hont</surname><given-names>Jinke</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-1" hwp:rel-id="aff-12">12</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-1" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-16"><name name-style="western" hwp:sortable="Dibb Katharine"><surname>Dibb</surname><given-names>Katharine</given-names></name><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-1" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-17"><name name-style="western" hwp:sortable="Eudy James D."><surname>Eudy</surname><given-names>James D.</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-1" hwp:rel-id="aff-15">15</xref></contrib><contrib contrib-type="author" hwp:id="contrib-18"><name name-style="western" hwp:sortable="Gan Lin"><surname>Gan</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-1" hwp:rel-id="aff-16">16</xref></contrib><contrib contrib-type="author" hwp:id="contrib-19"><name name-style="western" hwp:sortable="Gao Jing"><surname>Gao</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="a44" hwp:id="xref-aff-44-1" hwp:rel-id="aff-44">44</xref></contrib><contrib contrib-type="author" hwp:id="contrib-20"><name name-style="western" hwp:sortable="Gonzales Amy"><surname>Gonzales</surname><given-names>Amy</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-21"><name name-style="western" hwp:sortable="Guntur Anyonya"><surname>Guntur</surname><given-names>Anyonya</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-3" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-22"><name name-style="western" hwp:sortable="Guo Huiping"><surname>Guo</surname><given-names>Huiping</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-4" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-23"><name name-style="western" hwp:sortable="Harms Donald W."><surname>Harms</surname><given-names>Donald W.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-24"><name name-style="western" hwp:sortable="Harrington Anne"><surname>Harrington</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-4" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-25"><name name-style="western" hwp:sortable="Hentges Kathryn E."><surname>Hentges</surname><given-names>Kathryn E.</given-names></name><xref ref-type="aff" rid="a17" hwp:id="xref-aff-17-1" hwp:rel-id="aff-17">17</xref></contrib><contrib contrib-type="author" hwp:id="contrib-26"><name name-style="western" hwp:sortable="Humphreys Neil"><surname>Humphreys</surname><given-names>Neil</given-names></name><xref ref-type="aff" rid="a18" hwp:id="xref-aff-18-1" hwp:rel-id="aff-18">18</xref></contrib><contrib contrib-type="author" hwp:id="contrib-27"><name name-style="western" hwp:sortable="Imai Shiho"><surname>Imai</surname><given-names>Shiho</given-names></name><xref ref-type="aff" rid="a19" hwp:id="xref-aff-19-1" hwp:rel-id="aff-19">19</xref></contrib><contrib contrib-type="author" hwp:id="contrib-28"><name name-style="western" hwp:sortable="Ishii Hideshi"><surname>Ishii</surname><given-names>Hideshi</given-names></name><xref ref-type="aff" rid="a20" hwp:id="xref-aff-20-1" hwp:rel-id="aff-20">20</xref></contrib><contrib contrib-type="author" hwp:id="contrib-29"><name name-style="western" hwp:sortable="Iwama Mizuho"><surname>Iwama</surname><given-names>Mizuho</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-30"><name name-style="western" hwp:sortable="Jonasch Eric"><surname>Jonasch</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-1" hwp:rel-id="aff-21">21</xref></contrib><contrib contrib-type="author" hwp:id="contrib-31"><name name-style="western" hwp:sortable="Karolak Michelle"><surname>Karolak</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-2" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-32"><name name-style="western" hwp:sortable="Keavney Bernard"><surname>Keavney</surname><given-names>Bernard</given-names></name><xref ref-type="aff" rid="a22" hwp:id="xref-aff-22-1" hwp:rel-id="aff-22">22</xref></contrib><contrib contrib-type="author" hwp:id="contrib-33"><name name-style="western" hwp:sortable="Khin Nay-Chi"><surname>Khin</surname><given-names>Nay-Chi</given-names></name><xref ref-type="aff" rid="a44" hwp:id="xref-aff-44-2" hwp:rel-id="aff-44">44</xref></contrib><contrib contrib-type="author" hwp:id="contrib-34"><name name-style="western" hwp:sortable="Konno Masamitsu"><surname>Konno</surname><given-names>Masamitsu</given-names></name><xref ref-type="aff" rid="a23" hwp:id="xref-aff-23-1" hwp:rel-id="aff-23">23</xref></contrib><contrib contrib-type="author" hwp:id="contrib-35"><name name-style="western" hwp:sortable="Kotani Yuko"><surname>Kotani</surname><given-names>Yuko</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-1" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-36"><name name-style="western" hwp:sortable="Kunihiro Yayoi"><surname>Kunihiro</surname><given-names>Yayoi</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-2" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-37"><name name-style="western" hwp:sortable="Lakshmanan Imayavaramban"><surname>Lakshmanan</surname><given-names>Imayavaramban</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-38"><name name-style="western" hwp:sortable="Larochelle Catherine"><surname>Larochelle</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="a25" hwp:id="xref-aff-25-1" hwp:rel-id="aff-25">25</xref></contrib><contrib contrib-type="author" hwp:id="contrib-39"><name name-style="western" hwp:sortable="Lawrence Catherine B."><surname>Lawrence</surname><given-names>Catherine B.</given-names></name><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-2" hwp:rel-id="aff-10">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-40"><name name-style="western" hwp:sortable="Li Lin"><surname>Li</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="a26" hwp:id="xref-aff-26-1" hwp:rel-id="aff-26">26</xref></contrib><contrib contrib-type="author" hwp:id="contrib-41"><name name-style="western" hwp:sortable="Lindner Volkhard"><surname>Lindner</surname><given-names>Volkhard</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-5" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-42"><name name-style="western" hwp:sortable="Liu Xian-De"><surname>Liu</surname><given-names>Xian-De</given-names></name><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-2" hwp:rel-id="aff-21">21</xref></contrib><contrib contrib-type="author" hwp:id="contrib-43"><name name-style="western" hwp:sortable="Lopez-Castejon Gloria"><surname>Lopez-Castejon</surname><given-names>Gloria</given-names></name><xref ref-type="aff" rid="a27" hwp:id="xref-aff-27-1" hwp:rel-id="aff-27">27</xref></contrib><contrib contrib-type="author" hwp:id="contrib-44"><name name-style="western" hwp:sortable="Loudon Andrew"><surname>Loudon</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="a28" hwp:id="xref-aff-28-1" hwp:rel-id="aff-28">28</xref></contrib><contrib contrib-type="author" hwp:id="contrib-45"><name name-style="western" hwp:sortable="Lowe Jenna"><surname>Lowe</surname><given-names>Jenna</given-names></name><xref ref-type="aff" rid="a44" hwp:id="xref-aff-44-3" hwp:rel-id="aff-44">44</xref></contrib><contrib contrib-type="author" hwp:id="contrib-46"><name name-style="western" hwp:sortable="Jerome-Majeweska Loydie"><surname>Jerome-Majeweska</surname><given-names>Loydie</given-names></name><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-2" hwp:rel-id="aff-7">7</xref></contrib><contrib contrib-type="author" hwp:id="contrib-47"><name name-style="western" hwp:sortable="Matsusaka Taiji"><surname>Matsusaka</surname><given-names>Taiji</given-names></name><xref ref-type="aff" rid="a19" hwp:id="xref-aff-19-2" hwp:rel-id="aff-19">19</xref></contrib><contrib contrib-type="author" hwp:id="contrib-48"><name name-style="western" hwp:sortable="Miura Hiromi"><surname>Miura</surname><given-names>Hiromi</given-names></name><xref ref-type="aff" rid="a29" hwp:id="xref-aff-29-1" hwp:rel-id="aff-29">29</xref><xref ref-type="aff" rid="a30" hwp:id="xref-aff-30-1" hwp:rel-id="aff-30">30</xref></contrib><contrib contrib-type="author" hwp:id="contrib-49"><name name-style="western" hwp:sortable="Miyasaka Yoshiki"><surname>Miyasaka</surname><given-names>Yoshiki</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-3" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-50"><name name-style="western" hwp:sortable="Morpurgo Benjamin"><surname>Morpurgo</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-5" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-51"><name name-style="western" hwp:sortable="Motyl Katherine"><surname>Motyl</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-6" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-52"><name name-style="western" hwp:sortable="Nabeshima Yo-ichi"><surname>Nabeshima</surname><given-names>Yo-ichi</given-names></name><xref ref-type="aff" rid="a31" hwp:id="xref-aff-31-1" hwp:rel-id="aff-31">31</xref></contrib><contrib contrib-type="author" hwp:id="contrib-53"><name name-style="western" hwp:sortable="Nakade Koji"><surname>Nakade</surname><given-names>Koji</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-3" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-54"><name name-style="western" hwp:sortable="Nakashiba Toshiaki"><surname>Nakashiba</surname><given-names>Toshiaki</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-4" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-55"><name name-style="western" hwp:sortable="Nakashima Kenichi"><surname>Nakashima</surname><given-names>Kenichi</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-5" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-56"><name name-style="western" hwp:sortable="Obata Yuichi"><surname>Obata</surname><given-names>Yuichi</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-6" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-57"><name name-style="western" hwp:sortable="Ogiwara Sanae"><surname>Ogiwara</surname><given-names>Sanae</given-names></name><xref ref-type="aff" rid="a32" hwp:id="xref-aff-32-1" hwp:rel-id="aff-32">32</xref></contrib><contrib contrib-type="author" hwp:id="contrib-58"><name name-style="western" hwp:sortable="Ouellet Mariette"><surname>Ouellet</surname><given-names>Mariette</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-3" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-59"><name name-style="western" hwp:sortable="Oxburgh Leif"><surname>Oxburgh</surname><given-names>Leif</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-7" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-60"><name name-style="western" hwp:sortable="Piltz Sandra"><surname>Piltz</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-2" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-61"><name name-style="western" hwp:sortable="Pinz Ilka"><surname>Pinz</surname><given-names>Ilka</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-8" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-62"><name name-style="western" hwp:sortable="Ponnusamy Moorthy P."><surname>Ponnusamy</surname><given-names>Moorthy P.</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-3" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-63"><name name-style="western" hwp:sortable="Ray David"><surname>Ray</surname><given-names>David</given-names></name><xref ref-type="aff" rid="a33" hwp:id="xref-aff-33-1" hwp:rel-id="aff-33">33</xref></contrib><contrib contrib-type="author" hwp:id="contrib-64"><name name-style="western" hwp:sortable="Redder Ronald J."><surname>Redder</surname><given-names>Ronald J.</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-2" hwp:rel-id="aff-15">15</xref></contrib><contrib contrib-type="author" hwp:id="contrib-65"><name name-style="western" hwp:sortable="Rosen Clifford J"><surname>Rosen</surname><given-names>Clifford J</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-9" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-66"><name name-style="western" hwp:sortable="Ross Nikki"><surname>Ross</surname><given-names>Nikki</given-names></name><xref ref-type="aff" rid="a44" hwp:id="xref-aff-44-4" hwp:rel-id="aff-44">44</xref></contrib><contrib contrib-type="author" hwp:id="contrib-67"><name name-style="western" hwp:sortable="Ruhe Mark T."><surname>Ruhe</surname><given-names>Mark T.</given-names></name><xref ref-type="aff" rid="a34" hwp:id="xref-aff-34-1" hwp:rel-id="aff-34">34</xref></contrib><contrib contrib-type="author" hwp:id="contrib-68"><name name-style="western" hwp:sortable="Ryzhova Larisa"><surname>Ryzhova</surname><given-names>Larisa</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-10" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-69"><name name-style="western" hwp:sortable="Salvador Ane M."><surname>Salvador</surname><given-names>Ane M.</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-3" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-70"><name name-style="western" hwp:sortable="Sedlacek Radislav"><surname>Sedlacek</surname><given-names>Radislav</given-names></name><xref ref-type="aff" rid="a35" hwp:id="xref-aff-35-1" hwp:rel-id="aff-35">35</xref></contrib><contrib contrib-type="author" hwp:id="contrib-71"><name name-style="western" hwp:sortable="Sharma Karan"><surname>Sharma</surname><given-names>Karan</given-names></name><xref ref-type="aff" rid="a36" hwp:id="xref-aff-36-1" hwp:rel-id="aff-36">36</xref></contrib><contrib contrib-type="author" hwp:id="contrib-72"><name name-style="western" hwp:sortable="Smith Chad"><surname>Smith</surname><given-names>Chad</given-names></name><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-3" hwp:rel-id="aff-21">21</xref></contrib><contrib contrib-type="author" hwp:id="contrib-73"><name name-style="western" hwp:sortable="Staes Katrien"><surname>Staes</surname><given-names>Katrien</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-2" hwp:rel-id="aff-12">12</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-2" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-74"><name name-style="western" hwp:sortable="Starrs Lora"><surname>Starrs</surname><given-names>Lora</given-names></name><xref ref-type="aff" rid="a44" hwp:id="xref-aff-44-5" hwp:rel-id="aff-44">44</xref></contrib><contrib contrib-type="author" hwp:id="contrib-75"><name name-style="western" hwp:sortable="Sugiyama Fumihiro"><surname>Sugiyama</surname><given-names>Fumihiro</given-names></name><xref ref-type="aff" rid="a37" hwp:id="xref-aff-37-1" hwp:rel-id="aff-37">37</xref></contrib><contrib contrib-type="author" hwp:id="contrib-76"><name name-style="western" hwp:sortable="Takahashi Satoru"><surname>Takahashi</surname><given-names>Satoru</given-names></name><xref ref-type="aff" rid="a37" hwp:id="xref-aff-37-2" hwp:rel-id="aff-37">37</xref></contrib><contrib contrib-type="author" hwp:id="contrib-77"><name name-style="western" hwp:sortable="Tanaka Tomohiro"><surname>Tanaka</surname><given-names>Tomohiro</given-names></name><xref ref-type="aff" rid="a38" hwp:id="xref-aff-38-1" hwp:rel-id="aff-38">38</xref></contrib><contrib contrib-type="author" hwp:id="contrib-78"><name name-style="western" hwp:sortable="Trafford Andrew"><surname>Trafford</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-2" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-79"><name name-style="western" hwp:sortable="Uno Yoshihiro"><surname>Uno</surname><given-names>Yoshihiro</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-4" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-80"><name name-style="western" hwp:sortable="Vanhoutte Leen"><surname>Vanhoutte</surname><given-names>Leen</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-3" hwp:rel-id="aff-12">12</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-3" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-81"><name name-style="western" hwp:sortable="Vanrockeghem Frederique"><surname>Vanrockeghem</surname><given-names>Frederique</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-4" hwp:rel-id="aff-12">12</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-4" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-82"><name name-style="western" hwp:sortable="Willis Brandon J."><surname>Willis</surname><given-names>Brandon J.</given-names></name><xref ref-type="aff" rid="a34" hwp:id="xref-aff-34-2" hwp:rel-id="aff-34">34</xref></contrib><contrib contrib-type="author" hwp:id="contrib-83"><name name-style="western" hwp:sortable="Wright Christian S."><surname>Wright</surname><given-names>Christian S.</given-names></name><xref ref-type="aff" rid="a39" hwp:id="xref-aff-39-1" hwp:rel-id="aff-39">39</xref></contrib><contrib contrib-type="author" hwp:id="contrib-84"><name name-style="western" hwp:sortable="Yamauchi Yuko"><surname>Yamauchi</surname><given-names>Yuko</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-5" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-85"><name name-style="western" hwp:sortable="Yi Xin"><surname>Yi</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="a39" hwp:id="xref-aff-39-2" hwp:rel-id="aff-39">39</xref></contrib><contrib contrib-type="author" hwp:id="contrib-86"><name name-style="western" hwp:sortable="Yoshimi Kazuto"><surname>Yoshimi</surname><given-names>Kazuto</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-6" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-87"><name name-style="western" hwp:sortable="Zhang Xuesong"><surname>Zhang</surname><given-names>Xuesong</given-names></name><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-4" hwp:rel-id="aff-21">21</xref></contrib><contrib contrib-type="author" hwp:id="contrib-88"><name name-style="western" hwp:sortable="Zhang Yu"><surname>Zhang</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="a26" hwp:id="xref-aff-26-2" hwp:rel-id="aff-26">26</xref></contrib><contrib contrib-type="author" hwp:id="contrib-89"><name name-style="western" hwp:sortable="Ohtsuka Masato"><surname>Ohtsuka</surname><given-names>Masato</given-names></name><xref ref-type="aff" rid="a29" hwp:id="xref-aff-29-2" hwp:rel-id="aff-29">29</xref><xref ref-type="aff" rid="a30" hwp:id="xref-aff-30-2" hwp:rel-id="aff-30">30</xref></contrib><contrib contrib-type="author" hwp:id="contrib-90"><name name-style="western" hwp:sortable="Das Satyabrata"><surname>Das</surname><given-names>Satyabrata</given-names></name><xref ref-type="aff" rid="a40" hwp:id="xref-aff-40-1" hwp:rel-id="aff-40">40</xref></contrib><contrib contrib-type="author" hwp:id="contrib-91"><name name-style="western" hwp:sortable="Garry Daniel J."><surname>Garry</surname><given-names>Daniel J.</given-names></name><xref ref-type="aff" rid="a40" hwp:id="xref-aff-40-2" hwp:rel-id="aff-40">40</xref><xref ref-type="aff" rid="a41" hwp:id="xref-aff-41-1" hwp:rel-id="aff-41">41</xref></contrib><contrib contrib-type="author" hwp:id="contrib-92"><name name-style="western" hwp:sortable="Hochepied Tino"><surname>Hochepied</surname><given-names>Tino</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-5" hwp:rel-id="aff-12">12</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-5" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-93"><name name-style="western" hwp:sortable="Thomas Paul"><surname>Thomas</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-3" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-94"><name name-style="western" hwp:sortable="Parker-Thornburg Jan"><surname>Parker-Thornburg</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-5" hwp:rel-id="aff-21">21</xref></contrib><contrib contrib-type="author" hwp:id="contrib-95"><name name-style="western" hwp:sortable="Adamson Antony D"><surname>Adamson</surname><given-names>Antony D</given-names></name><xref ref-type="aff" rid="a18" hwp:id="xref-aff-18-2" hwp:rel-id="aff-18">18</xref></contrib><contrib contrib-type="author" hwp:id="contrib-96"><name name-style="western" hwp:sortable="Yoshiki Atsushi"><surname>Yoshiki</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-7" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-97"><name name-style="western" hwp:sortable="Schmouth Jean-Francois"><surname>Schmouth</surname><given-names>Jean-Francois</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-4" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-98"><name name-style="western" hwp:sortable="Golovko Andrei"><surname>Golovko</surname><given-names>Andrei</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-6" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-99"><name name-style="western" hwp:sortable="Thompson William R."><surname>Thompson</surname><given-names>William R.</given-names></name><xref ref-type="aff" rid="a39" hwp:id="xref-aff-39-3" hwp:rel-id="aff-39">39</xref></contrib><contrib contrib-type="author" hwp:id="contrib-100"><name name-style="western" hwp:sortable="Lloyd KC. Kent"><surname>Lloyd</surname><given-names>KC. Kent</given-names></name><xref ref-type="aff" rid="a34" hwp:id="xref-aff-34-3" hwp:rel-id="aff-34">34</xref><xref ref-type="aff" rid="a42" hwp:id="xref-aff-42-1" hwp:rel-id="aff-42">42</xref></contrib><contrib contrib-type="author" hwp:id="contrib-101"><name name-style="western" hwp:sortable="Wood Joshua A."><surname>Wood</surname><given-names>Joshua A.</given-names></name><xref ref-type="aff" rid="a34" hwp:id="xref-aff-34-4" hwp:rel-id="aff-34">34</xref></contrib><contrib contrib-type="author" hwp:id="contrib-102"><name name-style="western" hwp:sortable="Cowan Mitra"><surname>Cowan</surname><given-names>Mitra</given-names></name><xref ref-type="aff" rid="a43" hwp:id="xref-aff-43-1" hwp:rel-id="aff-43">43</xref></contrib><contrib contrib-type="author" hwp:id="contrib-103"><name name-style="western" hwp:sortable="Mashimo Tomoji"><surname>Mashimo</surname><given-names>Tomoji</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-7" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-104"><name name-style="western" hwp:sortable="Mizuno Seiya"><surname>Mizuno</surname><given-names>Seiya</given-names></name><xref ref-type="aff" rid="a37" hwp:id="xref-aff-37-3" hwp:rel-id="aff-37">37</xref></contrib><contrib contrib-type="author" hwp:id="contrib-105"><name name-style="western" hwp:sortable="Zhu Hao"><surname>Zhu</surname><given-names>Hao</given-names></name><xref ref-type="aff" rid="a26" hwp:id="xref-aff-26-3" hwp:rel-id="aff-26">26</xref></contrib><contrib contrib-type="author" hwp:id="contrib-106"><name name-style="western" hwp:sortable="Kasparek Petr"><surname>Kasparek</surname><given-names>Petr</given-names></name><xref ref-type="aff" rid="a35" hwp:id="xref-aff-35-2" hwp:rel-id="aff-35">35</xref></contrib><contrib contrib-type="author" hwp:id="contrib-107"><name name-style="western" hwp:sortable="Liaw Lucy"><surname>Liaw</surname><given-names>Lucy</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-11" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-108"><name name-style="western" hwp:sortable="Miano Joseph M."><surname>Miano</surname><given-names>Joseph M.</given-names></name><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-2" hwp:rel-id="aff-16">16</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-109"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7434-926X</contrib-id><name name-style="western" hwp:sortable="Burgio Gaetan"><surname>Burgio</surname><given-names>Gaetan</given-names></name><xref ref-type="aff" rid="a44" hwp:id="xref-aff-44-6" hwp:rel-id="aff-44">44</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-7434-926X"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3"><label>1</label><institution hwp:id="institution-1">Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center</institution>, Omaha, NE, <country>USA</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1"><label>2</label><institution hwp:id="institution-2">Developmental Neuroscience, Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center</institution>, Omaha, NE, <country>USA</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3 xref-aff-3-4 xref-aff-3-5 xref-aff-3-6"><label>3</label><institution hwp:id="institution-3">Texas A&amp;M Institute for Genomic Medicine (TIGM), Texas A&amp;M University</institution>, College Station, TX 77843, <country>USA</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2 xref-aff-4-3"><label>4</label><institution hwp:id="institution-4">Department of Immunology, Tufts University School of Medicine</institution>, Boston, <country>USA</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2 xref-aff-5-3 xref-aff-5-4 xref-aff-5-5 xref-aff-5-6 xref-aff-5-7"><label>5</label><institution hwp:id="institution-5">RIKEN BioResource Research Center</institution>, Tsukuba, Ibaraki 305-0074, <country>Japan</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2 xref-aff-6-3"><label>6</label><institution hwp:id="institution-6">Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center</institution>, Omaha, NE, <country>USA</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1 xref-aff-7-2"><label>7</label><institution hwp:id="institution-7">Departments of Anatomy and Cell Biology, Human Genetics and Pediatrics, Research Institute McGill University Health Center (RI-MUHC)</institution>, Montreal, <country>Canada</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1 xref-aff-8-2 xref-aff-8-3 xref-aff-8-4 xref-aff-8-5 xref-aff-8-6 xref-aff-8-7 xref-aff-8-8 xref-aff-8-9 xref-aff-8-10 xref-aff-8-11"><label>8</label><institution hwp:id="institution-8">Maine Medical Center Research Institute (MMCRI)</institution>, Scarborough, ME, <country>USA</country></aff><aff id="a9" hwp:id="aff-9" hwp:rev-id="xref-aff-9-1 xref-aff-9-2 xref-aff-9-3 xref-aff-9-4"><label>9</label><institution hwp:id="institution-9">Transgenesis and Animal Modeling Core Facility, Centre de Recherche du Centre Hospitalier Universitaire de Montreal (CRCHUM)</institution>, Montreal, <country>Canada</country></aff><aff id="a10" hwp:id="aff-10" hwp:rev-id="xref-aff-10-1 xref-aff-10-2"><label>10</label><institution hwp:id="institution-10">Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, AV Hill Building, Oxford Road</institution>, Manchester, M13 9PT, <country>U.K</country></aff><aff id="a11" hwp:id="aff-11" hwp:rev-id="xref-aff-11-1 xref-aff-11-2 xref-aff-11-3"><label>11</label><institution hwp:id="institution-11">South Australian Health &amp; Medical Research Institute and Department of Medicine, University of Adelaide</institution>, <country>Australia</country></aff><aff id="a12" hwp:id="aff-12" hwp:rev-id="xref-aff-12-1 xref-aff-12-2 xref-aff-12-3 xref-aff-12-4 xref-aff-12-5"><label>12</label><institution hwp:id="institution-12">Transgenic mouse core facility, VIB Center for Inflammation Research</institution>, Ghent, <country>Belgium</country></aff><aff id="a13" hwp:id="aff-13" hwp:rev-id="xref-aff-13-1 xref-aff-13-2 xref-aff-13-3 xref-aff-13-4 xref-aff-13-5"><label>13</label><institution hwp:id="institution-13">Department of Biomedical Molecular Biology, Ghent University</institution>, Ghent, <country>Belgium</country></aff><aff id="a14" hwp:id="aff-14" hwp:rev-id="xref-aff-14-1 xref-aff-14-2"><label>14</label><institution hwp:id="institution-14">Unit of Cardiac Physiology, School of Medical Sciences, Manchester Academic Health Science Center, University of Manchester</institution>, <country>UK</country></aff><aff id="a15" hwp:id="aff-15" hwp:rev-id="xref-aff-15-1 xref-aff-15-2"><label>15</label><institution hwp:id="institution-15">High-Throughput DNA Sequencing and Genotyping Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center</institution>, Omaha, <country>USA</country></aff><aff id="a16" hwp:id="aff-16" hwp:rev-id="xref-aff-16-1 xref-aff-16-2"><label>16</label><institution hwp:id="institution-16">University of Rochester Medical Center</institution>, Rochester, NY 14642, <country>USA</country></aff><aff id="a17" hwp:id="aff-17" hwp:rev-id="xref-aff-17-1"><label>17</label><institution hwp:id="institution-17">Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester</institution>, <country>UK</country></aff><aff id="a18" hwp:id="aff-18" hwp:rev-id="xref-aff-18-1 xref-aff-18-2"><label>18</label><institution hwp:id="institution-18">Transgenic Unit core facility, Faculty of Biology, Medicine and Health, University of Manchester</institution>, Manchester, <country>UK</country></aff><aff id="a19" hwp:id="aff-19" hwp:rev-id="xref-aff-19-1 xref-aff-19-2"><label>19</label><institution hwp:id="institution-19">Department of Basic Medicine, Division of Basic Medical Science and Molecular Medicine</institution>, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, <country>Japan</country></aff><aff id="a20" hwp:id="aff-20" hwp:rev-id="xref-aff-20-1"><label>20</label><institution hwp:id="institution-20">Department of Medical Data Science, Osaka University Graduate School of Medicine</institution>, <country>Japan</country></aff><aff id="a21" hwp:id="aff-21" hwp:rev-id="xref-aff-21-1 xref-aff-21-2 xref-aff-21-3 xref-aff-21-4 xref-aff-21-5"><label>21</label><institution hwp:id="institution-21">The University of Texas, MD Anderson Cancer Center</institution>, Houston, TX, <country>USA</country></aff><aff id="a22" hwp:id="aff-22" hwp:rev-id="xref-aff-22-1"><label>22</label><institution hwp:id="institution-22">Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester AND Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre</institution>, Manchester, <country>UK</country></aff><aff id="a23" hwp:id="aff-23" hwp:rev-id="xref-aff-23-1"><label>23</label><institution hwp:id="institution-23">Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine</institution>, Osaka, <country>Japan</country></aff><aff id="a24" hwp:id="aff-24" hwp:rev-id="xref-aff-24-1 xref-aff-24-2 xref-aff-24-3 xref-aff-24-4 xref-aff-24-5 xref-aff-24-6 xref-aff-24-7"><label>24</label><institution hwp:id="institution-24">The Institute of Experimental Animal Sciences, Osaka University Graduate School of Medicine</institution>, Osaka, <country>Japan</country></aff><aff id="a25" hwp:id="aff-25" hwp:rev-id="xref-aff-25-1"><label>25</label><institution hwp:id="institution-25">Centre de Recherche du Centre Hospitalier Universitaire de Montreal (CRCHUM)</institution>, Montreal, <country>Canada</country></aff><aff id="a26" hwp:id="aff-26" hwp:rev-id="xref-aff-26-1 xref-aff-26-2 xref-aff-26-3"><label>26</label><institution hwp:id="institution-26">Children’s Research Institute Mouse Genome Engineering Core, University of Texas Southwestern Medical Center</institution>, Dallas, TX 75390, <country>USA</country></aff><aff id="a27" hwp:id="aff-27" hwp:rev-id="xref-aff-27-1"><label>27</label><institution hwp:id="institution-27">Manchester Collaborative Centre for Inflammation Research (MCCIR), School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester</institution>, Manchester, <country>UK</country></aff><aff id="a28" hwp:id="aff-28" hwp:rev-id="xref-aff-28-1"><label>28</label><institution hwp:id="institution-28">Centre for Biological Timing</institution>, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, <country>UK</country></aff><aff id="a29" hwp:id="aff-29" hwp:rev-id="xref-aff-29-1 xref-aff-29-2"><label>29</label><institution hwp:id="institution-29">Center for Matrix Biology and Medicine</institution>, Graduate School of Medicine, Tokai University, Isehara, Kanagawa, 259-1193, <country>Japan</country></aff><aff id="a30" hwp:id="aff-30" hwp:rev-id="xref-aff-30-1 xref-aff-30-2"><label>30</label><institution hwp:id="institution-30">Department of Molecular Life Science</institution>, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, <country>Japan</country></aff><aff id="a31" hwp:id="aff-31" hwp:rev-id="xref-aff-31-1"><label>31</label><institution hwp:id="institution-31">Laboratory of Molecular Life Science</institution>, Foundation for Biomedical Research and Innovation, at Kobe, <country>Japan</country></aff><aff id="a32" hwp:id="aff-32" hwp:rev-id="xref-aff-32-1"><label>32</label><institution hwp:id="institution-32">Department of Laboratory Animal Science</institution>, Support Center for Medical Research and Education, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, <country>Japan</country></aff><aff id="a33" hwp:id="aff-33" hwp:rev-id="xref-aff-33-1"><label>33</label><institution hwp:id="institution-33">Oxford Centre for Diabetes</institution>, Endocrinology and Metabolism, University of Oxford, Oxford, OX37LE, <country>UK</country></aff><aff id="a34" hwp:id="aff-34" hwp:rev-id="xref-aff-34-1 xref-aff-34-2 xref-aff-34-3 xref-aff-34-4"><label>34</label><institution hwp:id="institution-34">Mouse Biology Program, University of California</institution>, Davis, <country>USA</country></aff><aff id="a35" hwp:id="aff-35" hwp:rev-id="xref-aff-35-1 xref-aff-35-2"><label>35</label><institution hwp:id="institution-35">Laboratory of Transgenic Models of Diseases and Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences</institution>, <country>Czech Republic</country></aff><aff id="a36" hwp:id="aff-36" hwp:rev-id="xref-aff-36-1"><label>36</label><institution hwp:id="institution-36">College of Osteopathic Medicine, Marian University</institution>, Indianapolis, IN 46222, <country>USA</country></aff><aff id="a37" hwp:id="aff-37" hwp:rev-id="xref-aff-37-1 xref-aff-37-2 xref-aff-37-3"><label>37</label><institution hwp:id="institution-37">Laboratory Animal Resource Center, University of Tsukuba</institution>, <country>Japan</country></aff><aff id="a38" hwp:id="aff-38" hwp:rev-id="xref-aff-38-1"><label>38</label><institution hwp:id="institution-38">Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences</institution>, Nagoya, Japan.</aff><aff id="a39" hwp:id="aff-39" hwp:rev-id="xref-aff-39-1 xref-aff-39-2 xref-aff-39-3"><label>39</label><institution hwp:id="institution-39">School of Health and Human Sciences, Department of Physical Therapy, Indiana University, Indianapolis</institution>, IN 46202, <country>USA</country></aff><aff id="a40" hwp:id="aff-40" hwp:rev-id="xref-aff-40-1 xref-aff-40-2"><label>40</label><institution hwp:id="institution-40">Lillehei Heart Institute Regenerative Medicine and Sciences Program, University of Minnesota, Minneapolis</institution>, MN, <country>USA</country></aff><aff id="a41" hwp:id="aff-41" hwp:rev-id="xref-aff-41-1"><label>41</label><institution hwp:id="institution-41">Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota</institution>, Minneapolis, MN, <country>USA</country></aff><aff id="a42" hwp:id="aff-42" hwp:rev-id="xref-aff-42-1"><label>42</label><institution hwp:id="institution-42">Dept. of Surgery, School of Medicine, University of California</institution>, Davis, Davis, <country>USA</country></aff><aff id="a43" hwp:id="aff-43" hwp:rev-id="xref-aff-43-1"><label>43</label><institution hwp:id="institution-43">McGill Integrated Core for Animal Modeling (MICAM)</institution>, Montreal, <country>Canada</country></aff><aff id="a44" hwp:id="aff-44" hwp:rev-id="xref-aff-44-1 xref-aff-44-2 xref-aff-44-3 xref-aff-44-4 xref-aff-44-5 xref-aff-44-6"><label>44</label><institution hwp:id="institution-44">Department of Immunology and Infectious Disease, the John Curtin School of Medical Research, the Australian National University</institution>, Canberra, <country>Australia</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2018"><year>2018</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-08-30T22:21:09-07:00">
    <day>30</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2018-08-30T22:21:09-07:00">
    <day>30</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-08-30T22:27:58-07:00">
    <day>30</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2018-08-30T22:27:58-07:00">
    <day>30</day><month>8</month><year>2018</year>
  </pub-date><elocation-id>393231</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-08-29"><day>29</day><month>8</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2018-08-29"><day>29</day><month>8</month><year>2018</year></date>
<date date-type="accepted" hwp:start="2018-08-30"><day>30</day><month>8</month><year>2018</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2018</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/" hwp:id="license-1"><p hwp:id="p-1">This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by/4.0/</ext-link></p></license></permissions><self-uri xlink:href="393231.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/393231v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="393231.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/393231v1/393231v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/393231v1/393231v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">CRISPR-Cas9 gene editing technology has considerably facilitated the generation of mouse knockout alleles, relieving many of the cumbersome and time-consuming steps of traditional mouse embryonic stem cell technology. However, the generation of conditional knockout alleles remains an important challenge. An earlier study reported up to 16% efficiency in generating conditional knockout alleles in mice using 2 single guide RNAs (sgRNA) and 2 single-stranded oligonucleotides (ssODN) (2sgRNA-2ssODN). We re-evaluated this method from a large data set generated from a consortium consisting of 17 transgenic core facilities or laboratories or programs across the world. The dataset constituted 17,887 microinjected or electroporated zygotes and 1,718 live born mice, of which only 15 (0.87%) mice harbored 2 correct <italic toggle="yes">LoxP</italic> insertions in <italic toggle="yes">cis</italic> configuration indicating a very low efficiency of the method. To determine the factors required to successfully generate conditional alleles using the 2sgRNA-2ssODN approach, we performed a generalized linear regression model. We show that factors such as the concentration of the sgRNA, Cas9 protein or the distance between the placement of <italic toggle="yes">LoxP</italic> insertions were not predictive for the success of this technique. The major predictor affecting the method’s success was the probability of simultaneously inserting intact proximal and distal <italic toggle="yes">LoxP</italic> sequences, without the loss of the DNA segment between the two sgRNA cleavage sites. Our analysis of a large data set indicates that the 2sgRNA–2ssODN method generates a large number of undesired alleles (&gt;99%), and a very small number of desired alleles (&lt;1%) requiring, on average 1,192 zygotes.</p></abstract><counts><page-count count="38"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">Introduction</title><p hwp:id="p-3">Many inherited diseases are caused by defective genes. A better understanding of the mechanisms of these defects is critical to obtaining precise diagnoses and finding new therapeutics. Gene inactivation through knockout alleles in model organisms such as flies, worms, zebrafish and mice provides invaluable insights into mechanisms of gene function and disease [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>]. However important challenges remain to successfully analyze the phenotypic impact of knockout genes in adult model organisms as over 30% of the genes in mice are essential for development and cause embryo lethality or neonatal subviability when deleted [<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>]. To overcome lethal phenotypes in gene-knockout models, conditional knockout (cKO) strategies have emerged [<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>]. cKO models usually involve insertion of <italic toggle="yes">LoxP</italic> sites in introns flanking critical exon/s or (less commonly) in intergenic regions or flanking regulatory regions such as promoters and enhancers. When crossed with a <italic toggle="yes">Cre</italic> recombinase expressing driver mouse, the <italic toggle="yes">Cre</italic> enzyme recognizes <italic toggle="yes">LoxP</italic> sequences and removes the intervening sequence. This leads to functional inactivation of the targeted gene in only the cells where the <italic toggle="yes">Cre</italic> is expressed and capable of targeting the DNA [<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref>]. Generating a cKO mouse previously required the use of embryonic stem (ES) cell-based homologous recombination in combination with embryo manipulation, microinjection (MI), and assisted reproduction technologies (ART) [<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>]. These techniques were established in the 1980s and are still being used as gold-standard methods. Based on this technology, large-scale efforts such as the KnockOut Mouse Project (KOMP) [<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>] and the European Conditional Mouse Mutagenesis (EUCOMM) Program [<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>] have designed thousands of gene targeted constructs in ES cells for over 90% of coding genes. Using the ES cell clones, about 25% of mouse genes have been converted into cKO mice, all readily available and accessible in public repositories [<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>].</p><p hwp:id="p-4">The recent emergence of genome editing technologies such as ZFN, TALENS and CRISPR-Cas9 enables an improvement in efficiency of gene targeting and has considerably facilitated the generation of genetically-engineered animal models based on homology directed repair of donor constructs in mouse zygotes [<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>]. Endonucleases, particularly Class 2 CRISPR systems, generate a precise double strand break (DSB) in the DNA under a chimeric single guide RNA (sgRNA) [<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>]. The DSB leads to error-prone, non-homologous end joining (NHEJ) repair or the precise homology-directed repair (HDR) under the guidance of a repair template [<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">8</xref>]. In an earlier study, a high success rate (16%) of targeting <italic toggle="yes">LoxP</italic> sites in <italic toggle="yes">cis</italic> was reported by using 2 sgRNAs and 2 single-stranded oligonucleotides (ssODN) containing <italic toggle="yes">LoxP</italic> sites (2sgRNA-2ssODN) flanking a targeted critical exon (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1</xref>) [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>].</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1:</label><caption hwp:id="caption-1"><title hwp:id="title-3">Schematic of 2sgRNA-2ssODN CRISPR method of creating conditional knockout alleles.</title><p hwp:id="p-5">(A) Wild type locus showing exons 3, 4 and 5 of a hypothetical gene where exon 4 is chosen as a target exon for inserting <italic toggle="yes">LoxP</italic> sites. The guide 1 and the guide 2 target introns 3 and 4 respectively. (B) CRISPR components showing 2sgRNA-2ssODN donors and a Cas9 source. (C) Delivery of CRISPR components into zygotes via microinjection (n=17,557) or electroporation (n=330). (D) The conditional knockout (cKO) allele showing target exon (#4) with flanking <italic toggle="yes">LoxP</italic> sites.</p></caption><graphic xlink:href="393231_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-6">We sought to investigate the efficiency of the 2sgRNA-2ssODN method for the generation of cKO alleles. We describe here for the first time a global community effort from a consortium of over a dozen laboratories, transgenic core facilities and programs across the world to evaluate the efficiency of generating cKO alleles using the 2sgRNA-2ssODN approach. We surveyed over 50 loci and over 17,000 microinjected or electroporated zygotes using this method, which enabled robust statistical power to evaluate the efficiency of the technique. In contrast to the earlier report [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref>], we find this method does not efficiently produce cKO alleles. Rather, it generally results in a series of undesired editing events at the cleavage sites which occur nearly 100 fold higher rate than the precise insertion, in <italic toggle="yes">cis</italic>, of the two <italic toggle="yes">LoxP</italic> sites.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-4">Material and methods</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-5">Ethical statement</title><p hwp:id="p-7">All experiments were approved from the respective Institutional Animal Care and Use Committees in the USA and Ethics Committees in Australia, Belgium, Czech Republic, Japan, Spain and UK according to guidelines or code of practice from the National Institute of Health in the USA, the National Health and Medical Research Council (NHMRC) in Australia, Animals (Scientific Procedures) Act 1986 in UK or MEXT (Ministry of Education, culture, sports, Science and Technology), MHLW (The Ministry of Health, Labor and Welfare) in Japan, the central commission for Animal Welfare (CCAW) in Czech Republic, the Canadian Council on Animal Care (CCAC) in Canada, the National Ethics Code from the Royal Belgian (Flemish) Academy of Medicine in Belgium, and the European code of Conduct for Research Integrity from All European Academies.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-6"><italic toggle="yes">Mecp2</italic> gene targeting using CRISPR-Cas9</title><p hwp:id="p-8"><italic toggle="yes">Mecp2</italic> left single chimeric guide RNAs (sgRNA) 5’-CCCAAGGATACAGTATCCTA-3’ and <italic toggle="yes">Mecp2</italic> right sgRNA 5’-AGGAGTGAGGTCTAGTACTT-3’ target sites were designed as described in Yang et al [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-3" hwp:rel-id="ref-10">10</xref>]. Ultramer Oligonucleotides (Integrated DNA Technologies, Coralville, IA) were designed with sequences to T7 promoter for <italic toggle="yes">in vitro</italic> transcription, DNA target region, and chimeric RNA sequence. Complimentary oligos for each target sequence were annealed at 95°C for 5 mins and the temperature was reduced 0.20°C/second to 16°C using a PCR machine (BioRad T100) before use as template for sgRNA synthesis. sgRNAs were synthesized with the HiScribe(tm) T7 Quick High Yield RNA Synthesis Kit (New England Biolabs). Cas9 mRNA was obtained from Life Technologies or in-vitro transcribed from a Chimeric pX330-U6-Chinmeric-BB-CBh-hSpCas9 expression plasmid obtained from Addgene repository (Plasmid 42230; donation from Zhang laboratory).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-7">SgRNA design</title><p hwp:id="p-9">SgRNAs were designed using available online tools such as CRISPOR, Chop-Chop or CCTop [<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>, <xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>]. SgRNAs were cloned into pX330 and <italic toggle="yes">in vitro</italic> transcribed[<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>-<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>], or synthesized and annealed [<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>]. Cas9 mRNA or protein was purchased, <italic toggle="yes">in vitro</italic> transcribed or purified in house. Cas9 protein was complexed with thesgRNA or crRNA and the tracrRNA [<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>] and then mixed with the ssODN prior to microinjection. Concentrations and site of injection for Cas9 protein or mRNA, sgRNA, and template repairs for each locus are indicated in <xref rid="tblS1" ref-type="table" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Supplementary Table 1</xref>.</p><table-wrap id="tblS1" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2 xref-table-wrap-2-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/TBLS1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tblS1</object-id><label>Supplementary Table 1</label><caption hwp:id="caption-5"><p hwp:id="p-26">Single Guide RNA, Single Stranded Oligonucleotide DNA sequences, reagents concentrations and targeting genomic regions (in bp) used in this study.</p></caption><graphic xlink:href="393231_tblS1" position="float" orientation="portrait" hwp:id="graphic-5"/><graphic xlink:href="393231_tblS1a" position="float" orientation="portrait" hwp:id="graphic-6"/><graphic xlink:href="393231_tblS1b" position="float" orientation="portrait" hwp:id="graphic-7"/><graphic xlink:href="393231_tblS1c" position="float" orientation="portrait" hwp:id="graphic-8"/><graphic xlink:href="393231_tblS1d" position="float" orientation="portrait" hwp:id="graphic-9"/></table-wrap></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-8">Mouse husbandry and zygote microinjection and electroporation</title><p hwp:id="p-10">Mice were purchased from various sources and maintained under specific pathogen-free conditions. Mice were maintained under 12/12 hr light cycle and food and water were provided <italic toggle="yes">ad libitum</italic>. Three to five week-old females were superovulated by intraperitoneal injection of Pregnant Mare Serum Gonadotropin (5IU) followed by intraperitoneal injection of Human Chorionic Gonadotropin hormone (5IU) 48 hours later. Superovulated females were mated with 8 to 20 week-old stud males. The mated females were euthanized the following day and the zygotes were collected from their oviducts. Cytoplasmic or pronuclear injections were performed under an inverted microscope, associated micromanipulators, and a microinjection apparatus. Electroporation of the embryos were performed with an electroporation device using a cuvette or 1mm plate electrodes with the following parameters: 30 V square wave pulses with 100 ms interval using a BioRad electroporator device or 4 poring pulses (40 V, 3.5 ms, interval 50 ms, 10% voltage decay + polarity) followed by 5 transfer pulses (5 V, 50 ms, interval 50 ms, 40% voltage decay, alternating + and - polarity) using a NEPA21 electroporator device. Microinjected or electroporated zygotes were either surgically transferred into the ampulla of pseudo-pregnant females or cultured overnight at 37°C and then surgically transferred at the 2-cell stage of development.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-9">Genotyping</title><p hwp:id="p-11">DNA extraction was performed on ear punch or tail tip from mouse pups over 15 days using a DNA extraction kit according to the manufacturer instructions. Primers were designed to amplify the regions encompassing the integrated <italic toggle="yes">LoxP</italic> sequence. PCR was performed using Taq polymerase under standard PCR conditions. The PCR products were then purified with ExoSAP-IT1 or a PCR Clean-Up System kit according to the manufacturer’s instructions. Sanger sequencing was performed in core facilities. To identify <italic toggle="yes">LoxP</italic> insertions, as a general practice at all centers, the two target sites were amplified individually to look for increase in the amplicon size, which occurs if <italic toggle="yes">LoxP</italic> sites are inserted successfully. If the <italic toggle="yes">LoxP</italic> insertion was not observed in this first set of PCR analyses, the samples were declared negative, and in many such cases the samples were not analyzed further (as the end goal of the project, ie., generation of floxed allele was not met). In some cases, such samples were also sequenced to assess <italic toggle="yes">indels</italic> to understand if the guides were successful in cleaving the target site. In some cases, the entire regions encompassing both the guide cleavage sites were amplified to assess for deletions between the cleavage sites.</p></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-10">Statistics</title><p hwp:id="p-12">To determine the statistical differences between proportions or means, we performed a Fisher Exact test or a Kruskal Wallis sum rank test. A Generalized linear model calculation was performed with success of the 2sgRNA-2ssODN method as a response. Predictive variables were: efficiency of the sgRNA, probability of <italic toggle="yes">LoxP</italic> insertions in 5’ and 3 (5’_<italic toggle="yes">LoxP</italic> and 3’_<italic toggle="yes">LoxP</italic>), simultaneous insertion of the 2 <italic toggle="yes">LoxP</italic> sites (interaction between 5’_<italic toggle="yes">Loxp</italic> and 3’_<italic toggle="yes">LoxP</italic>) Cas9 mRNA, protein, plasmid and ssODN concentrations and distance between distal and proximal target sites. Variance for each predictor was determined from the diagonal of the variance-covariance matrix. Effect sizes and type II error were determined using Cohen effect size d statistics and power calculation. All statistical analyses were performed using Rstudio v1.1.423. Results were considered statistically significant at p&lt;0.05.</p></sec></sec><sec id="s3" hwp:id="sec-9"><title hwp:id="title-11">Results</title><sec id="s3a" hwp:id="sec-10"><title hwp:id="title-12"><italic toggle="yes">Mecp2</italic> gene targeting in blastocysts</title><p hwp:id="p-13">To assess the efficiency of the technique and compare to previously published results [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-4" hwp:rel-id="ref-10">10</xref>], we reproduced an experiment on <italic toggle="yes">Mecp2</italic> gene, essential for DNA methylation during development using the same sgRNAs and ssODNs as previously described in the original report [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-5" hwp:rel-id="ref-10">10</xref>]. Three independent centers at the Australian National University in Australia (ANU), University of Nebraska Medical Center in the USA (UNMC) and the Czech Centre for Phenogenomics in Czech Republic (IMG) performed these experiments on C57BL/6N inbred strain of mice. We evaluated the success rate of the 2sgRNA-2ssODN method in blastocysts for <italic toggle="yes">Mecp2</italic> (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>). Using a concentration mix of 20 ng/µl of Cas9 mRNA, 20 ng/µl of in-vitro transcribed sgRNA, and 10 ng/µl of ssODN, we observed no successful targeting (i.e., correct insertion of 2 <italic toggle="yes">LoxP</italic> sites in <italic toggle="yes">cis</italic> configuration) even though both sgRNAs cleaved target DNA as indicated by the presence of <italic toggle="yes">indels</italic> or integration of a <italic toggle="yes">LoxP</italic> site at the desired location, which varied from 13% to 34% (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>).</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1:</label><caption hwp:id="caption-2"><p hwp:id="p-14">Summary of the edited blastocysts for <italic toggle="yes">Mecp2</italic> gene from three different centers.</p></caption><graphic xlink:href="393231_tbl1" position="float" orientation="portrait" hwp:id="graphic-2"/></table-wrap><p hwp:id="p-15">Interestingly we noted the occasional presence of mutations within <italic toggle="yes">LoxP</italic> sites indicating illegitimate repair events at the target site. The frequency of successful targeting of two <italic toggle="yes">LoxP</italic> sites <italic toggle="yes">in cis</italic> was previously reported to be 16% [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-6" hwp:rel-id="ref-10">10</xref>], which we failed to achieve. One possible explanation is the mouse genetic background influences the likelihood of ssODN integration. This variance could also be explained by an inherently low probability to successfully replace 2 genomic loci in <italic toggle="yes">cis</italic>, the lack of efficiency of the sgRNA, or the relatively low sample size.</p></sec><sec id="s3b" hwp:id="sec-11"><title hwp:id="title-13">A global survey of the generation of conditional alleles using 2sgRNA-2ssODN method</title><p hwp:id="p-16">To better understand how to successfully generate conditional alleles using the 2sgRNA– 2ssODN approach and to assess its efficiency, we evaluated this method on 56 additional genes and two intergenic regions of the mouse genome from a consortium of 17 institutions across Australia, Belgium, Japan, USA, UK, Czech Republic and Canada. A majority of attempts were performed on a C57BL/6J background (39) whereas 18 projects used C57BL/6N background and 3 additional ones used a hybrid mouse background (B6C3HF1, B6SJLF1, FVBCD1F1). We assessed whether the mouse background strain would have an impact over the success of the method using Fisher Exact test statistics. We failed to find such evidence in our data (Fisher exact test, p = 0.74). Out of the 56 targeted loci (49 microinjected and 7 electroporated), 21 were ranked as essential genes based on early embryonic or postnatal lethality of the homozygous knockout mice according to mouse genome database <ext-link l:rel="related" l:ref-type="uri" l:ref="http://sudheer.zinovyevcurie.com" ext-link-type="uri" xlink:href="http://sudheer.zinovyevcurie.com" hwp:id="ext-link-2">http://www.informatics.jax.org</ext-link> [<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>]. Different knockout mice from 18 out of 56 targeted loci were described viable to adulthood as homozygous mice and 17 loci were unknown. Together this indicates the repartition between putative essential and non-essential targeted gene was in equal frequency (Fisher exact test, p = 0.76). The distance between sgRNA varied from 250 bp to 1.1 Mb with a median of 2 Kb. Single exons to entire genes or regulatory genomic regions (<xref rid="tblS1" ref-type="table" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2">Supplementary Table 1</xref>) were floxed. We investigated whether the distance between sgRNA is critical for the likelihood of success of the 2sgRNA-2ssODN method. We failed to find such evidence in our data set (Kruskal Wallis rank sum test, chi-squared = 32, p=0.42), although the sample size was too low to form a conclusion (Cohen’s effect size d = 0.40 with power 1-beta = 0.27). Among the microinjected zygotes in 53 Loci, significantly higher number of zygotes were microinjected in the pronucleus alone (26/53) than the cytoplasm alone (10/53) or pronucleus and cytoplasm (17/53) (Fischer exact test p = 0.004), which is consistent with the current practice in most mouse transgenic core facilities (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2A</xref>). Various forms of CRISPR reagents (sgRNA, Cas9 and ssODN), were microinjected or electroporated to generate the models (<xref rid="tblS1" ref-type="table" hwp:id="xref-table-wrap-2-3" hwp:rel-id="T2">Supplementary Table 1</xref>). Consistent with the general practice in mouse transgenic facilities from 2013 to 2016 using CRISPR-Cas9 gene editing technology, the majority of the reagents were delivered in 59 Loci (49 unique loci microinjected, 3 different designs for one loci and 7 electroporated Loci) in the form of in-vitro transcribed mRNA (35/59) at various concentrations varying from 10 ng/µl to 100 ng/µl of Cas9 mRNA (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2B</xref>) and from 10 ng/µl to 50 ng/µl sgRNA. ssODN were delivered at a concentration varying from 10 ng/µl to 200 ng/µl. In 18 instances, Cas9 was delivered as protein with a concentration varying from 10 ng/µl to 75 ng/µl. Interestingly for 6 loci, Cas9 and sgRNAs were delivered in the form of a chimeric sgRNA-SpCas9 plasmid (pX330) at a concentration of 5 ng/µl. We sought to determine whether the forms of reagent delivery such as plasmid, ribonucleoprotein (RNP) or mRNA would have an effect on the overall efficiency in targeting using the 2sgRNA-2ssODN method. We failed to find such evidence (Fisher exact test p = 1). We therefore hypothesized that the success in generating floxed alleles using the 2sgRNA-2ssODN approach may depend on factors such as: (i) sgRNA efficiency, (ii) simultaneity in <italic toggle="yes">LoxP</italic> insertion, or; (iii) the concentration of the Cas9, sgRNA and ssODN reagents. To get insight on these possibilities, we further analyzed data from the 56 loci (<xref rid="tblS2" ref-type="table" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Supplementary Table 2</xref>, <xref rid="tblS4" ref-type="table" hwp:id="xref-table-wrap-5-1" hwp:rel-id="T5">4</xref> and <xref rid="tblS5" ref-type="table" hwp:id="xref-table-wrap-6-1" hwp:rel-id="T6">5</xref>). Note that the offspring for 54 loci were analyzed post-natal stage (Supplementary Tables 2 and 4) whereas 2 loci were analyzed at the blastocyst stage (Supplementary Table 4). Out of 17,887 (17,557 microinjected and 330 electroporated; see details below) zygotes, 12,764 (71.4%) zygotes were surgically transferred into recipient females. The recipient females gave birth to 1,718 pups (9.6% of the microinjected/electroporated zygotes). As a general practice, at all centers, the mice were first analyzed by PCR to observe the putative insertion of the <italic toggle="yes">LoxP</italic> sites at both the sites; the animals were declared negative if genotyping did not reveal the presence of the desired allele. In some cases the loci were further analyzed to assess guide cleaving activity. Of the 1,684 founder mice, 659 (39%) showed some type of editing (<italic toggle="yes">indels</italic> and/or substitutions), 235 (14%) and 144 (9%)mice harbored a single <italic toggle="yes">LoxP</italic> insertion or deletions between the two cleavage sites, respectively (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2C</xref>). The mice for 25 (of the 56) loci were further assessed for additional events including large deletions (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figure 2C</xref>). Of the 487 founder mice analyzed (from those 25 loci), 41%, 11% and 2.7% samples contained <italic toggle="yes">indels,</italic> single <italic toggle="yes">LoxP</italic> insertions or large deletions respectively (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Figure 2D</xref>). From the 1,684 animals analyzed, only 15 mice (0.87%) were correctly targeted with intact <italic toggle="yes">LoxP</italic> sites in the <italic toggle="yes">cis</italic> configuration (Supplementary Table 5). Out of 56 loci only 11 loci were successfully targeted (19.6%). The average number of zygotes needed to generate 1 correctly targeted animal was 1,192. The essentiality of the genes had no impact on the likelihood of success of the 2sgRNA-2ssODN technique (4/23 success in targeting for embryonic or postnatal lethality versus 5/18 for viable homozygous mice and 2/15 for unknown embryonic or postnatal lethality, Fisher exact test p = 0.27). We also noted from our data, among the 56 loci analyzed 14% loci showed deletions between two target sites for Cas9 cleavage. We also noted a relatively high occurrence of single <italic toggle="yes">LoxP</italic> insertions for &gt; 20% of the mice genotyped (from all the loci) and few instances of <italic toggle="yes">trans LoxP</italic> insertions (on different alleles, reducing the probability for correct insertion of the <italic toggle="yes">LoxP</italic> sites) (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3</xref>). We therefore hypothesized that success of this approach depends on the combined efficiency of the sgRNA and the likelihood of <italic toggle="yes">LoxP</italic> insertion on both sites to enable two <italic toggle="yes">in cis</italic> HDR events to occur simultaneously. To assess this postulate, we performed a generalized linear regression analysis to model the relationship between Cas9, sgRNA concentration, sgRNA cleavage efficiency, distance between <italic toggle="yes">LoxP</italic> insertions, occurrences of <italic toggle="yes">LoxP</italic> insertions, and success of the 2sgRNA-2ssODN method. The analyses are summarized in Supplementary Table 3. The efficiency of <italic toggle="yes">LoxP</italic> insertions at both 5’ and 3’ sites appears to be the best predictor for the likelihood of success of the 2sgRNA-2ssODN method accounting for over 60% of the total variance.</p><table-wrap id="tblS2" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/TBLS2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tblS2</object-id><label>Supplementary Table 2</label><caption hwp:id="caption-6"><p hwp:id="p-27">Detailed count of the numbers of zygotes microinjected, transferred, live pups born, correctly targerted and non targeted from 49 unique loci</p></caption><graphic xlink:href="393231_tblS2" position="float" orientation="portrait" hwp:id="graphic-10"/><graphic xlink:href="393231_tblS2a" position="float" orientation="portrait" hwp:id="graphic-11"/></table-wrap><table-wrap id="tblS3" orientation="portrait" position="float" hwp:id="T4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/TBLS3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tblS3</object-id><label>Supplementary Table 3</label><caption hwp:id="caption-7"><p hwp:id="p-28">Generalized Regression analysis to identify the factors predicting the success of the 2sgRNA-2ssODN methods</p></caption><graphic xlink:href="393231_tblS3" position="float" orientation="portrait" hwp:id="graphic-12"/></table-wrap><table-wrap id="tblS4" orientation="portrait" position="float" hwp:id="T5" hwp:rev-id="xref-table-wrap-5-1 xref-table-wrap-5-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/TBLS4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T5</object-id><object-id pub-id-type="publisher-id">tblS4</object-id><label>Supplementary Table 4</label><caption hwp:id="caption-8"><p hwp:id="p-29">Detailed count of the numbers of zygotes electroporated, live pups born or blastocysts genotyped, correctly targeted and non targeted from 7 unique loci</p></caption><graphic xlink:href="393231_tblS4" position="float" orientation="portrait" hwp:id="graphic-13"/></table-wrap><table-wrap id="tblS5" orientation="portrait" position="float" hwp:id="T6" hwp:rev-id="xref-table-wrap-6-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/TBLS5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T6</object-id><object-id pub-id-type="publisher-id">tblS5</object-id><label>Supplementary Table 5</label><caption hwp:id="caption-9"><p hwp:id="p-30">Overall efficiency of the 2sgRNA-2ssODN method of generating the cKO alleles</p></caption><graphic xlink:href="393231_tblS5" position="float" orientation="portrait" hwp:id="graphic-14"/></table-wrap><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2:</label><caption hwp:id="caption-3"><title hwp:id="title-14">Quantitative assessment of the 2sgRNA-2ssODN methods</title><p hwp:id="p-17">(A) Doughnut graph indicating the methods of zygote injections (pronuclear, cytoplasmic or both) of the CRISPR reagents. Numbers indicate the percentage of the total zygotes microinjected or electroporated. (B) Doughnut graph indicating the form of delivery of the CRISPR reagents (mRNA, protein or plasmid) in the zygotes. Numbers indicate percentages. (C) Flow chart indicating the number of successful edited alleles and correct <italic toggle="yes">LoxP</italic> insertions out of the number of live born pups from microinjected and transferred zygotes. Numbers indicate absolute numbers. (D) Doughnut chart indicating the editing types observed amongst the live born pups genotyped on a sub sample from 25 loci. Numbers indicate absolute values.</p></caption><graphic xlink:href="393231_fig2" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;393231v1/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3:</label><caption hwp:id="caption-4"><title hwp:id="title-15">Desired and undesired outcomes of the 2sgRNA-2ssODN CRISPR method of creating conditional knockout alleles.</title><p hwp:id="p-18">(A). Desired outcome showing a floxed allele and its occurrence is &lt;1%. (B) to (F): various undesired outcomes including only one <italic toggle="yes">LoxP</italic> site insertion (B), only <italic toggle="yes">indels</italic> created at one or both sites (C), combination of <italic toggle="yes">LoxP</italic> insertion and <italic toggle="yes">indels</italic> (D), deletion between the two cleavage sites (E) and no <italic toggle="yes">indel</italic> or no insertion events (F).</p></caption><graphic xlink:href="393231_fig3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-19">However, this predictor was not significant in our linear regression model. Additional predictors such as sgRNA efficiency or efficiency in 5’- or 3’-insertion of <italic toggle="yes">LoxP</italic> explained approximately 35% of the total variance but none of these predictors were significant in our model. The concentration of Cas9 mRNA accounted less than 0.1% of the total variance but was statistically significant (p &lt;0.01) in the generalized linear regression model as a predictor for the success of the 2sgRNA-2ssODN approach. However, success of the 2sgRNA-2ssODN approach was not significantly correlated with an increase of Cas9 mRNA concentration (r<sup>2</sup> Pearson = 0.27, p=0.08). From our analysis, the sample size of the successful <italic toggle="yes">LoxP</italic> insertions in <italic toggle="yes">cis</italic> was too small to definitively rule out any others predictors (Cohen’s effect size d = 0.4, power 1-beta = 0.41). Together, these results suggest that the presence of two simultaneous HDR events is the best predictor to generating two floxed alleles in <italic toggle="yes">cis</italic>.</p><p hwp:id="p-20">Recently, electroporation of zygotes has been developed as an efficient method for generating knockout, point mutations, tagged, or conditional alleles [<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>-<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>]. From our consortium, 3 laboratories and programs surveyed the likelihood of success of the method. For 7 loci surveyed, we noted success in inserting a single <italic toggle="yes">LoxP</italic> allele (<xref rid="tblS4" ref-type="table" hwp:id="xref-table-wrap-5-2" hwp:rel-id="T5">Supplementary Table 4</xref>) from analysis of blastocysts or live mice for 2 out of the 7 loci. In contrast we noted a relatively high frequency of large deletions and <italic toggle="yes">indels</italic> (up to 39% of large deletions) indicating successful editing. However, none of the loci showed two <italic toggle="yes">LoxP</italic> sites inserted in <italic toggle="yes">cis</italic> in the offspring, suggesting that the delivery of CRISPR reagents by electroporation does not make a statistical difference in obtaining a desired outcome from the 2sgRNA-2ssODN floxing approach, although the large numbers of embryos that can be manipulated allows for the recovery of the very small number of those that are correctly targeted.</p></sec></sec><sec id="s4" hwp:id="sec-12"><title hwp:id="title-16">Discussion</title><p hwp:id="p-21">CRISPR-Cas9 technology has greatly facilitated the generation of mouse lines containing knockout or knockin alleles. However, the generation of conditional alleles remains a challenge using traditional ES cells and CRISPR-Cas9 gene editing technologies. An earlier paper demonstrated 16% efficiency with 2 chimeric sgRNAs and 2 single-stranded oligonucleotides to produce conditional alleles in mice [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-7" hwp:rel-id="ref-10">10</xref>].</p><p hwp:id="p-22">To evaluate the efficiency of this 2sgRNA-2ssODN method, three laboratories replicated the experiments described in the initial report on <italic toggle="yes">Mecp2</italic> (10) using the same methods to generate the sgRNA and Cas9 and microinjected the mouse zygotes at similar reagent concentrations. Although we observed single <italic toggle="yes">LoxP</italic> site insertions and <italic toggle="yes">indels</italic> at the cleavage sites, the method was unsuccessful in generating two <italic toggle="yes">LoxP</italic> sites in <italic toggle="yes">cis</italic>. A previous report attempting to replicate the findings of Yang et al [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-8" hwp:rel-id="ref-10">10</xref>], found an efficiency of floxing <italic toggle="yes">Mecp2</italic> varying from 2% to 8% with the 2sgRNA-2ssODN approach [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>]. We surmise the lack of efficiency in targeting <italic toggle="yes">Mecp2</italic> here was due to a low concentration of reagents delivered by microinjection, a notion corroborated by previous work from Horii and colleagues [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-2" hwp:rel-id="ref-26">26</xref>]. Of note, it was reported that up to 6% targeting efficiency was achieved using 25 ng/µl of Cas9, 6 ng/µl of sgRNA and 100 ng/µl of ssODN but toxic to embryonic development; these concentrations are 2-fold higher than those described in Yang <italic toggle="yes">et al,</italic> 2013 [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-9" hwp:rel-id="ref-10">10</xref>].</p><sec id="s4a" hwp:id="sec-13"><title hwp:id="title-17">What determines the success of the 2sgRNA-2ssODN method?</title><p hwp:id="p-23">To better understand the critical factors predicting the likelihood of success with the 2sgRNA-2ssODN approach, we surveyed 56 unique loci in mice zygote. We noted that the efficiency of simultaneous insertion of the two <italic toggle="yes">LoxP</italic> sites simultaneously was the best predictor of success using this approach. We also noted a low success rate in generating a conditional allele across all centers (&lt; 1%), varying from 0 to 50% (median = 0%) for individual loci. These results are comparable with previous reports demonstrating an important disparity in success rate varying from 0% to 7% of mice harboring two <italic toggle="yes">LoxP</italic> sites insertions in <italic toggle="yes">cis</italic> whether delivered by microinjection [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-3" hwp:rel-id="ref-26">26</xref>-<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>] or by electroporation [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-4" hwp:rel-id="ref-26">26</xref>]. We and others also have noted the large number of deletions at the target sites following DNA cleavage [<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>]. Our results on a larger number of loci suggest the efficiency in generating a successful cKO with the 2sgRNA-2ssODN method is lower than previously described [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-10" hwp:rel-id="ref-10">10</xref>]. One hypothesis for this discrepancy in success rate might relate to strain-specific differences. We analyzed this variable and did not find any significant differences among strains, whether the donor strain was a F1 cross, inbred, or outbred mouse line as a donor strain. Another possibility to improve the efficiency of the method is to avoid recombination between the target sites by placing the <italic toggle="yes">LoxP</italic> sites hundreds of kb apart. This was reported previously for a success rate varying from 0% to 18% for 6 loci [<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>]. We did not find such evidence in our data, although our sample size is too small to formally rule out this hypothesis. A recent report found the successful use of sequential introduction of the <italic toggle="yes">LoxP</italic> sites to improve efficiency and avoid recombination between alleles [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-5" hwp:rel-id="ref-26">26</xref>]. Indeed, a 3 to 10 fold improvement in successful targeting was observed, though it should be noted that such an approach requires a more protracted period of time to completion [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-6" hwp:rel-id="ref-26">26</xref>]. Additional work has demonstrated over 5 fold improvement in targeting using a long ssODN [<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>, <xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">29</xref>, <xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>] or double-stranded donor DNA [<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref>].</p><p hwp:id="p-24">In conclusion, we find the 2sgRNA-2ssODN method to be inherently biased for <italic toggle="yes">indels</italic> or substitutions at the DSB, deletion between the guide cleavage sites, or <italic toggle="yes">trans</italic> insertion of the <italic toggle="yes">LoxP</italic> sites. Even though the overall success rate is very low — ∼1,200 zygotes were needed to generate 1 correctly targeted animal — it is possible to generate floxed alleles using CRISPR-Cas9 gene editing technology with 2sgRNA-2ssODN. The method, however, requires two inefficient simultaneous HDR events leading to correct insertion of both <italic toggle="yes">LoxP</italic> sites in the <italic toggle="yes">cis</italic> configuration, an outcome we find occurs very infrequently (&lt;1%).</p></sec></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-18">Acknowledgements</title><p hwp:id="p-25">This work was supported by the National Collaborative Research Infrastructure (NCRIS) via the Australian Phenomics Network (APN) (to Gaetan Burgio and Paul Thomas), by an Institutional Development Award (PI: Shelley Smith) P20GM103471 (to CBG, RMQ, DWH, JDE and RR), by NIGMS 1P30GM110768-01 and P30CA036727 (as part of support to University of Nebraska Mouse Genome Engineering and DNA Sequencing Cores), the British Heart Foundation (FS12-57), FS12/57/29717, CH/13/2/30154 and the program grant RG/15/12/31616 (to Kathryn Hentges and Bernard Keavney), the Wellcome Trust grants 107849/Z/15/Z and 105610/Z/14/Z, the Medical Research Council, MR/N029992/1 (to DB and CBL), the National BioResource Project of Ministry of Education, Culture, Sports, Science and Technology/Japan Agency for Medical Research and Development (MEXT/AMED), Japan, the Canadian Institutes of Health Research, MOP#142452 (MCB and LJM). LJM is a member of the Research Centre of the McGill University Health Centre which is supported in part by FQRS. Dr William Thompson was supported by the Indiana Clinical and Translational Sciences Institute, funded in part by grant #UL1 TR001108 from the National Institute of Health (NIH), National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. D Kent Lloyd is supported from the NIH (UM1OD023221), and work contributed by staff from the UC Davis Mouse Biology Program (MBP) is supported by a grant from the American College of Laboratory Animal Medicine. The work contributed from Xiande Liu, Chad Smith, Eric Jonasch, Xuesong Zhang and Jan Parker-Thornburg is supported from the NIH under the award number P30CA16672. R Sedlacek was supported by LM2015040 (Czech Centre for Phenogenomics), CZ.1.05/1.1.00/02.0109 (BIOCEV), and CZ.1.05/2.1.00/19.0395 by the Ministry of Education, Youth and Sports (MEYS) and by Academy of Sciences of the Czech Republic (RVO 68378050). David Ray was supported from a Wellcome Trust Investigator (107849/Z/15/Z) and the Medical Research Council (MR/P011853/1 and MR/P023576/) grants. Andrew Loudon was supported from a Wellcome Trust Investigator (107849/Z/15/Z), Biotechnology and Biological Sciences Research Council (BB/N015584/1), Medical Research Council (MR/P023576/1). The work contributed from Gloria Lopez-Castejon is supported from the Wellcome Trust (104192/Z/14/Z) and the Royal Society. Pilar Alcaide was supported from the NIH (HL 123658).</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-19">Literature Cited</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Lee D."><surname>Lee</surname>, <given-names>D.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Threadgill D.W."><given-names>D.W.</given-names> <surname>Threadgill</surname></string-name>, <article-title hwp:id="article-title-2">Investigating gene function using mouse models</article-title>. <source hwp:id="source-1">Curr Opin Genet Dev</source>, <year>2004</year>. <volume>14</volume>(<issue>3</issue>): p. <fpage>246</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Dickinson M.E."><surname>Dickinson</surname>, <given-names>M.E.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-3">High-throughput discovery of novel developmental phenotypes</article-title>. <source hwp:id="source-2">Nature</source>, <year>2016</year>. <volume>537</volume>(<issue>7621</issue>): p. <fpage>508</fpage>–<lpage>514</lpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Skarnes W.C."><surname>Skarnes</surname>, <given-names>W.C.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-4">A conditional knockout resource for the genome-wide study of mouse gene function</article-title>. <source hwp:id="source-3">Nature</source>, <year>2011</year> <volume>474</volume>(<issue>7351</issue>): p. <fpage>337</fpage>–<lpage>42</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Thomas K.R."><surname>Thomas</surname>, <given-names>K.R.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Capecchi M.R."><given-names>M.R.</given-names> <surname>Capecchi</surname></string-name>, <article-title hwp:id="article-title-5">Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells</article-title>. <source hwp:id="source-4">Cell</source>, <year>1987</year>. <volume>51</volume>(<issue>3</issue>): p. <fpage>503</fpage>–<lpage>12</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Austin C.P."><surname>Austin</surname>, <given-names>C.P.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-6">The knockout mouse project</article-title>. <source hwp:id="source-5">Nat Genet</source>, <year>2004</year>. <volume>36</volume>(<issue>9</issue>): p. <fpage>921</fpage>–<lpage>4</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Friedel R.H."><surname>Friedel</surname>, <given-names>R.H.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-7">EUCOMM--the European conditional mouse mutagenesis program</article-title>. <source hwp:id="source-6">Brief Funct Genomic Proteomic</source>, <year>2007</year>. <volume>6</volume>(<issue>3</issue>): p. <fpage>180</fpage>–<lpage>5</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Ayadi A."><surname>Ayadi</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-8">Mouse large-scale phenotyping initiatives: overview of the European Mouse Disease Clinic (EUMODIC) and of the Wellcome Trust Sanger Institute Mouse Genetics Project</article-title>. <source hwp:id="source-7">Mamm Genome</source>, <year>2012</year> <volume>23</volume>(<issue>9-10</issue>): p. <fpage>600</fpage>–<lpage>10</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Wang H."><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-9">One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering</article-title>. <source hwp:id="source-8">Cell</source>, <year>2013</year> <volume>153</volume>(<issue>4</issue>): p. <fpage>910</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Jinek M."><surname>Jinek</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-10">A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity</article-title>. <source hwp:id="source-9">Science</source>, <year>2012</year> <volume>337</volume>(<issue>6096</issue>): p. <fpage>816</fpage>–<lpage>21</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2 xref-ref-10-3 xref-ref-10-4 xref-ref-10-5 xref-ref-10-6 xref-ref-10-7 xref-ref-10-8 xref-ref-10-9 xref-ref-10-10"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Yang H."><surname>Yang</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-11">One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering</article-title>. <source hwp:id="source-10">Cell</source>, <year>2013</year> <volume>154</volume>(<issue>6</issue>): p. <fpage>1370</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Haeussler M."><surname>Haeussler</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-12">Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR</article-title>. <source hwp:id="source-11">Genome Biol</source>, <year>2016</year>. <volume>17</volume>(<issue>1</issue>): p. <fpage>148</fpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Stemmer M."><surname>Stemmer</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-13">CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool</article-title>. <source hwp:id="source-12">PLoS One</source>, <year>2015</year>. <volume>10</volume>(<issue>4</issue>): p. <fpage>e0124633</fpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Cong L."><surname>Cong</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-14">Multiplex genome engineering using CRISPR/Cas systems</article-title>. <source hwp:id="source-13">Science</source>, <year>2013</year>. <volume>339</volume>(<issue>6121</issue>): p. <fpage>819</fpage>–<lpage>23</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Harms D.W."><surname>Harms</surname>, <given-names>D.W.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-15">Mouse Genome Editing Using the CRISPR/Cas System</article-title>. <source hwp:id="source-14">Curr Protoc Hum Genet</source>, <year>2014</year>. <volume>83</volume>: p. <fpage>15.7.1</fpage>-<lpage>27</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Yang H."><surname>Yang</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang H."><given-names>H.</given-names> <surname>Wang</surname></string-name>, and <string-name name-style="western" hwp:sortable="Jaenisch R."><given-names>R.</given-names> <surname>Jaenisch</surname></string-name>, <article-title hwp:id="article-title-16">Generating genetically modified mice using CRISPR/Cas-mediated genome engineering</article-title>. <source hwp:id="source-15">Nat Protoc</source>, <year>2014</year>. <volume>9</volume>(<issue>8</issue>): p. <fpage>1956</fpage>–<lpage>68</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Bassett A.R."><surname>Bassett</surname>, <given-names>A.R.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-17">Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system</article-title>. <source hwp:id="source-16">Cell Rep</source>, <year>2013</year>. <volume>4</volume>(<issue>1</issue>): p. <fpage>220</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Aida T."><surname>Aida</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-18">Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice</article-title>. <source hwp:id="source-17">Genome Biol</source>, <year>2015</year>. <volume>16</volume>: p. <fpage>87</fpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Blake J.A."><surname>Blake</surname>, <given-names>J.A.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-19">The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse</article-title>. <source hwp:id="source-18">Nucleic Acids Res</source>, <year>2014</year>. <volume>42</volume>(<issue>Database issue</issue>): p. <fpage>D810</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Kaneko T."><surname>Kaneko</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-20">Simple knockout by electroporation of engineered endonucleases into intact rat embryos</article-title>. <source hwp:id="source-19">Sci Rep</source>, <year>2014</year>. <volume>4</volume>: p. <fpage>6382</fpage>.</citation></ref><ref id="c20" hwp:id="ref-20"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Chen S."><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-21">Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes</article-title>. <source hwp:id="source-20">J Biol Chem</source>, <year>2016</year>. <volume>291</volume>(<issue>28</issue>): p. <fpage>14457</fpage>–<lpage>67</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Hashimoto M."><surname>Hashimoto</surname>, <given-names>M.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Takemoto T."><given-names>T.</given-names> <surname>Takemoto</surname></string-name>, <article-title hwp:id="article-title-22">Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing</article-title>. <source hwp:id="source-21">Sci Rep</source>, <year>2015</year>. <volume>5</volume>: p. <fpage>11315</fpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Miyasaka Y."><surname>Miyasaka</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-23">CLICK: one-step generation of conditional knockout mice</article-title>. <source hwp:id="source-22">BMC Genomics</source>, <year>2018</year>. <volume>19</volume>(<issue>1</issue>): p. <fpage>318</fpage>.</citation></ref><ref id="c23" hwp:id="ref-23"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Ohtsuka M."><surname>Ohtsuka</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-24">i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases</article-title>. <source hwp:id="source-23">Genome Biol</source>, <year>2018</year>. <volume>19</volume>(<issue>1</issue>): p. <fpage>25</fpage>.</citation></ref><ref id="c24" hwp:id="ref-24"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Qin W."><surname>Qin</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-25">Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease</article-title>. <source hwp:id="source-24">Genetics</source>, <year>2015</year>. <volume>200</volume>(<issue>2</issue>): p. <fpage>423</fpage>–<lpage>30</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Teixeira M."><surname>Teixeira</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-26">Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing</article-title>. <source hwp:id="source-25">Sci Rep</source>, <year>2018</year>. <volume>8</volume>(<issue>1</issue>): p. <fpage>474</fpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1 xref-ref-26-2 xref-ref-26-3 xref-ref-26-4 xref-ref-26-5 xref-ref-26-6"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Horii T."><surname>Horii</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-27">Efficient generation of conditional knockout mice via sequential introduction of lox sites</article-title>. <source hwp:id="source-26">Sci Rep</source>, <year>2017</year>. <volume>7</volume>(<issue>1</issue>): p. <fpage>7891</fpage>.</citation></ref><ref id="c27" hwp:id="ref-27"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Bishop K.A."><surname>Bishop</surname>, <given-names>K.A.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-28">CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells</article-title>. <source hwp:id="source-27">G3 (Bethesda)</source>, <year>2016</year>. <volume>6</volume>(<issue>7</issue>): p. <fpage>2051</fpage>–<lpage>61</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Kueh A.J."><surname>Kueh</surname>, <given-names>A.J.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-29">An update on using CRISPR/Cas9 in the one-cell stage mouse embryo for generating complex mutant alleles</article-title>. <source hwp:id="source-28">Cell Death Differ</source>, <year>2017</year>. <volume>24</volume>(<issue>10</issue>): p. <fpage>1821</fpage>–<lpage>1822</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Lanza D.G."><surname>Lanza</surname>, <given-names>D.G.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-30">Comparative analysis of single-stranded DNA donors to generate conditional null mouse alleles</article-title>. <source hwp:id="source-29">BMC Biol</source>, <year>2018</year>. <volume>16</volume>(<issue>1</issue>): p. <fpage>69</fpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Pritchard C.E.J."><surname>Pritchard</surname>, <given-names>C.E.J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kroese L.J."><given-names>L.J.</given-names> <surname>Kroese</surname></string-name>, and <string-name name-style="western" hwp:sortable="Huijbers I.J."><given-names>I.J.</given-names> <surname>Huijbers</surname></string-name>, <article-title hwp:id="article-title-31">Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes</article-title>. <source hwp:id="source-30">Methods Mol Biol</source>, <year>2017</year>. <volume>1642</volume>: p. <fpage>21</fpage>–<lpage>35</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="393231v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Quadros R.M."><surname>Quadros</surname>, <given-names>R.M.</given-names></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-32">Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins</article-title>. <source hwp:id="source-31">Genome Biol</source>, <year>2017</year>. <volume>18</volume>(<issue>1</issue>): p. <fpage>92</fpage>.</citation></ref></ref-list></back></article>
